Latest Data & Signals Issued

Below are some of the latest signals issued for MacroGenics

General

Signal Type Signal Value Data
Score 3.224 1 day ( 0 %
Last Price $4.50 3.93 %
Performance History
7 Days
$4.57 $4.50
-1.53%
30 Days
$3.96 $4.50
13.64%
12 Mos
$1.61 $4.50
179.50%

11/18

Active Buy Signals

Specific Signals

Short Term
Net score: 73.08
Signal Type Signal Value Importance Data
High / Low Neutral Very Low $4.20 - $4.55
Position: 86.96% from low / 13.04% from high · Momentum: 13.18%
Trend - 3 mos 47.50 % High Width: 25.02 %
Pred. range - 3 mos $6.02 - $7.53 Low 33.78 % - 67.25 %
Volume Direction Buy High Volume: 934,137 · Direction: 1.00
Pivot Short Sell Very Low Jun 29, 2026 - 10 days
RSI Short Pivot Signal Sell Very Low Jul 08, 2026 - 4 days
Short MA 3 mos Buy Low Jul 06, 2026 - 6 days
Long MA 3 mos Sell Medium Jul 09, 2026 - 3 days
Short/Long MA 3 mos Buy Medium May 13, 2026 - 41 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 68.5
Signal Type Signal Value Importance Data
Trend - 12 mos 161.24 % Very High Width: 71.97 %
Pred. range - 12 mos $7.55 - $12.98 High 67.79 % - 188.55 %
Short MA 12 mos Sell Very High Jul 09, 2026 - 3 days
Long MA 12 mos Buy Very High Dec 30, 2025 - 133 days
Short/Long MA 12 mos Buy Very High Jan 13, 2026 - 124 days
Pivot Long Sell Low Jun 29, 2026 - 10 days
RSI Long Pivot Signal Buy Low Jul 10, 2026 - 2 days
Bollinger Buy Medium Jun 22, 2026 - 15 days
MACD Sell High No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Click to get the best stock tips daily for free!
ABOUT MACROGENICS
MacroGenics
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE